Radiation Oncology
Park, Hee Chul
95 AppointmentProfessor of Department of Radiation Oncology, Samsung Medical Center
Speciality Interests
Schedule
11 | MON 25 |
TUE 26 |
WEN 27 |
THU 28 |
FRI 29 |
---|---|---|---|---|---|
AM | available | ||||
PM | available | available |
Medical School
2002~2004 Ph.D. in Medicine Yonsei University, Korea 1999~2001 Master of Science Yonsei University, Korea 1986~1992 Medical Doctor College of Medicine, Yonsei University, Korea
Specialty Training
Fellowship | 2001~2001 Department of Radiation Oncology, Yonsei University College of Medicine, Korea | |
---|---|---|
Residency | 1996~2000 Department of Radiation Oncology, Severance Hospital, Korea | |
Internship | 1992~1993 Severance Hospital, Korea |
Other Education
2021~Present Chair Department of Radiation Oncology, Samsung Medical Center
2016~Present Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2010~2015 Associate Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2006~2007 Visiting Scientist Department of Radiation Oncology, MD Anderson Cancer Center, USA
2006~2006 Honorable Visiting Instructor Department of Radiology, Hokkaido University Hospital, Japan
2001~2005 Assistant Professor Department of Radiation Oncology, Hallym University College of Medicine
Participation in Academic Societies
and Research
1996~Present Member The Korean Society for Radiation Oncology
2009~Present Member The Korean Liver Cancer Association
2008~Present Member Korean Society of Medical Oncology
Thesis
J BONE ONCOL 2021 10.1016/j.jbo.2021.100368
Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases
SCI REP-UK 2021 10.1038/s41598-021-90065-1
Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma
INT J MOL SCI 2021 10.3390/ijms22052637
Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments
CELLS 2021 10.3390/cells10030554
Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells
SCI REP-UK 2021 10.1038/s41598-021-82177-5
Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma